Saturday, July 25, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
77

Quick answer

77 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9126941

    Treatment of hyperproliferative disorders with diarylhydantoin compounds

    The Regents of the University of California · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9127274

    Serpinc1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9132107

    Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

    Jazz Pharmaceuticals Ireland Limited · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9132096

    Abuse resistant pharmaceutical compositions

    REKHI GURVINDER SINGH [US] · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9133461

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9138404

    Treating critically ill patients with intravenous ibuprofen

    Cumberland Pharmaceuticals Inc. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9138432

    Methods for the administration of iloperidone

    VANDA PHARMACEUTICALS INC. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9150552

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9155775

    Process for manufacturing glatiramer acetate product

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9157121

    Method of treatment based on polymorphisms of the KCNQ1 gene

    VANDA PHARMACEUTICALS INC. · Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9156786

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9161936

    Laquinimod for treatment of GABA mediated disorders

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9161935

    Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9169238

    Solid pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9180091

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9180197

    Sustained delivery formulations of risperidone compounds

    Indivior UK Limited · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9180097

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9186411

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9186413

    Sustained delivery formulations of risperidone compounds

    Indivior UK Limited · Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9192590

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9193701

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9192606

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9198926

    Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9198882

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9205048

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9205044

    Aqueous pharmaceutical preparation comprising roflumilast

    TAKEDA GMBH · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9216969

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9216178

    Dry blend formulation of tetrahydrobiopterin

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9227918

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

77 published patents in our USPTO index have expiration dates falling in calendar year 2035.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.